StockNews.com upgraded shares of Biglari (NYSE:BH – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Wednesday morning.
Biglari Stock Performance
Shares of Biglari stock opened at $220.34 on Wednesday. The firm has a market cap of $502.38 million, a P/E ratio of 1.25 and a beta of 0.73. The company has a current ratio of 1.47, a quick ratio of 1.44 and a debt-to-equity ratio of 0.17. Biglari has a 12 month low of $145.95 and a 12 month high of $271.35. The stock’s fifty day moving average price is $226.87 and its 200-day moving average price is $195.60.
Insider Activity
In related news, CEO Sardar Biglari acquired 4,994 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The shares were bought at an average price of $247.33 per share, with a total value of $1,235,166.02. Following the completion of the transaction, the chief executive officer now directly owns 1,281,750 shares in the company, valued at $317,015,227.50. This trade represents a 0.39 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Over the last 90 days, insiders have bought 21,977 shares of company stock worth $6,342,966. Company insiders own 71.40% of the company’s stock.
Institutional Investors Weigh In On Biglari
About Biglari
Biglari Holdings Inc, through its subsidiaries, primarily operates and franchises restaurants in the United States. It owns, operates, and franchises restaurants under the Steak n Shake and Western Sizzlin names. The company also engages in underwriting commercial trucking insurance; selling physical damage and non-trucking liability insurance to truckers; and providing property and casualty insurance.
Further Reading
- Five stocks we like better than Biglari
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- Investing in Construction Stocks
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- EV Stocks and How to Profit from Them
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
Receive News & Ratings for Biglari Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biglari and related companies with MarketBeat.com's FREE daily email newsletter.